Acylcarnitines are anticoagulants that inhibit factor Xa and are reduced in venous thrombosis, based on metabolomics data
Hiroshi Deguchi(Scripps Research Institute), John H. Griffin(Scripps Research Institute), José A. Fernández(Scripps Research Institute), Subramanian Yegneswaran, Sunia A. Trauger(Harvard University Press), Gary Siuzdak(Scripps Research Institute), Darlene J. Elias(Scripps Clinic), Linh Hoang(Scripps Research Institute), Yajnavalka Banerjee(University of Dundee), Minerva Tran(Scripps Research Institute), Ewa Kalisiak(Scripps Research Institute)
Cited by 62
Related Papers
Metabolomics: the apogee of the omics trilogy
|Nature Reviews Molecular Cell Biology|2012|2.5k
Potential role of intratumor bacteria in mediating tumor resistance to the chemotherapeutic drug gemcitabine
|Science|2017|1.8k
Deficiency of protein C in congenital thrombotic disease.
|Journal of Clinical Investigation|1981|1.3k
METLIN: A Technology Platform for Identifying Knowns and Unknowns
|Analytical Chemistry|2018|951
The cytoprotective protein C pathway
|Blood|2006|747